Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Palmetto Issues Final LCD for Decipher Biosciences Prostate Cancer Test

Palmetto Issues Final LCD for Decipher Biosciences Prostate Cancer Test

Dec 03, 2019
|
staff reporter

NEW YORK – Decipher Biosciences announced on Tuesday that Medicare Administrative Contractor Palmetto GBA has issued a final local coverage determination (LCD) for the use of the company's Decipher Prostate Biopsy test in men diagnosed with favorable or unfavorable intermediate-risk prostate cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

To Get Back Going

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

UK COVID-19 Disparities Report

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

Trials Figure Out Paths Forward Despite Pandemic

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

Nature Papers Present CRISPR-Cas3 System to Make Large Genomic Deletions, Molecular Mechanisms of Chemoresistance in ALL

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.

What's Popular?

In Business News

  1. Abbott Q3 Diagnostics Revenues Increase 38 Percent

  2. Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing

  3. Danaher Q3 Revenues Up 35 Percent

  4. Sanofi Commits $1M to Support Parkinson's Disease Genetic Testing Study

  5. MDxHealth Q3 2020 Revenues Drop 6 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.